Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Monje

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Science Translational Medicine|November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screeningGrant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Nature Medicine|July 4, 2018
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cellsMara Vinci, Anna Burford, Valeria Molinari, et al.
Science (New York, N.Y.)|April 1, 2017
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seqAndrew S Venteicher, Itay Tirosh, Christine Hebert, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
Nature|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunitySean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh, et al.
Nature Medicine|May 5, 2015
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S Grasso, Yujie Tang, Nathalene Truffaux, et al.
Journal of the National Cancer Institute|September 9, 2024
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairmentMichelle C Janelsins, Kathleen Van Dyk, Sheri J Hartman, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Cell Reports. Medicine|June 21, 2023
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomasMarkus Bredel, Lluís Espinosa, Hyunsoo Kim, et al.
Nature|November 5, 2016
Single-cell RNA-seq supports a developmental hierarchy in human oligodendrogliomaItay Tirosh, Andrew S Venteicher, Christine Hebert, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Science Translational Medicine|November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screeningGrant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Nature Medicine|July 4, 2018
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cellsMara Vinci, Anna Burford, Valeria Molinari, et al.
Science (New York, N.Y.)|April 1, 2017
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seqAndrew S Venteicher, Itay Tirosh, Christine Hebert, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
Nature|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunitySean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh, et al.
Nature Medicine|May 5, 2015
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S Grasso, Yujie Tang, Nathalene Truffaux, et al.
Journal of the National Cancer Institute|September 9, 2024
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairmentMichelle C Janelsins, Kathleen Van Dyk, Sheri J Hartman, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Cell Reports. Medicine|June 21, 2023
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomasMarkus Bredel, Lluís Espinosa, Hyunsoo Kim, et al.
Nature|November 5, 2016
Single-cell RNA-seq supports a developmental hierarchy in human oligodendrogliomaItay Tirosh, Andrew S Venteicher, Christine Hebert, et al.
Pageof 19